The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Chagas Disease Drug Discovery: Toward a New Era
Open accessAbstract
American trypanosomiasis, or Chagas disease, is the result of infection by the Trypanosoma cruzi parasite. Endemic in Latin America where it is the major cause of death from cardiomyopathy, the impact of the disease is reaching global proportions through migrating populations. New drugs that are safe, efficacious, low cost, and adapted to the field are critically needed. Over the past five years, there has been increased interest in the disease and a surge in activities within various organizations. However, recent clinical trials with azoles, specifically posaconazole and the ravuconazole prodrug E1224, were disappointing, with treatment failure in Chagas patients reaching 70% to 90%, as opposed to 6% to 30% failure for benznidazole-treated patients. The lack of translation from in vitro and in vivo models to the clinic observed for the azoles raises several questions. There is a scientific requirement to review and challenge whether we are indeed using the right tools and decision-making processes to progress compounds forward for the treatment of this disease. New developments in the Chagas field, including new technologies and tools now available, will be discussed, and a redesign of the current screening strategy during the discovery process is proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Rassi, A., Rassi, A., & Marin-Neto, J. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60061-x · Cited by 2,119
Chagas, C. (1909) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02761909000200008 · Cited by 1,597
Zingales, B. S., Sg, A., Briones, M. R. S., Campbell, D. M., Chiari, E., Fernandes, O., Guhl, F., Lages‐Silva, E., Macedo, A. A. P., Machado, C. R., et al. (2009) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762009000700021 · Cited by 1,050
Hotez, P. J., Bottazzi, M. E., Franco-Paredes, C., Ault, S. K., & Periago, M. R. (2008) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000300 · Cited by 728
Global economic burden of Chagas disease: a computational simulation model
Lee, B. Y., Bacon, K. M., Bottazzi, M. E., & Hotez, P. J. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70002-1 · Cited by 616
Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
Molina, I., Gómez i Prat, J., Salvador, F., Treviño, B., Sulleiro, E., Serre, N., Pou, D., Roure, S., Cabezos, J., Valerio, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313122 · Cited by 604
Chagas disease in Spain, the United States and other non-endemic countries
Gascon, J., Bern, C., & Pinazo, M.-J. (2010) · Acta Tropica · doi:10.1016/j.actatropica.2009.07.019 · Cited by 601
AMERICAN TRYPANOSOMIASIS (CHAGAS' DISEASE): FIRST INDIGENOUS CASE IN THE UNITED STATES
Woody, N. C. (1955) · Journal of the American Medical Association · doi:10.1001/jama.1955.02960240042010a · Cited by 533
Cited by
Bern, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1410150 · Cited by 770
Hit and lead criteria in drug discovery for infectious diseases of the developing world
Katsuno, K., Burrows, J. N., Duncan, K., van Huijsduijnen, R. H., Kaneko, T., Kita, K., Mowbray, C. E., Schmatz, D., Warner, P., & Slingsby, B. T. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4683 · Cited by 607
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
Khare, S., Nagle, A. S., Biggart, A., Lai, Y. H., Liang, F., Davis, L. C., Barnes, S. W., Mathison, C. J. N., Myburgh, E., Gao, M.-Y., et al. (2016) · Nature · doi:10.1038/nature19339 · Cited by 407
Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery
Ekins, S., Lage de Siqueira-Neto, J., McCall, L.-I., Sarker, M., Yadav, M., Ponder, E. L., Kallel, E. A., Kellar, D., Chen, S., Arkin, M., et al. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0003878 · Cited by 93
Gulin, J. E. N., Rocco, D. M., & García-Bournissen, F. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004194 · Cited by 66
Metadata
- Authors
- Chatelain, E.
- Venue
- SLAS Discovery
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 20
- Issue
- 1
- Pages
- 22-35
- ISSN
- 2472-5552 (ISSN-L)
- OpenAlex
- W2151800668
- Cited by
- 312
- References
- 62
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chagas Disease Drug Discovery: Toward a New Era. https://app.cochat.ai/papers/10.1177/1087057114550585
- The paper
- Chatelain, E. (2015). Chagas Disease Drug Discovery: Toward a New Era. SLAS Discovery. https://doi.org/10.1177/1087057114550585
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.